- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02734563
Collagen Alterations in Patients With Abdominal Wall Hernias
July 14, 2017 updated by: Lars Nannestad Jorgensen, Bispebjerg Hospital
The aim of this study was to evaluate collagen turnover in patients with multiple hernias
Study Overview
Detailed Description
Venous blood was collected and markers for type IV and V collagen synthesis and breakdown was measured
Study Type
Observational
Enrollment (Actual)
174
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
NV
-
Copenhagen, NV, Denmark, DK-2400
- Bispebjerg Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Males with multiple hernias wer identified from the Danish Hernia Database.
The control group were recruited from hospital staff.
Description
Inclusion Criteria:
- patients with a history of three hernia repairs (multiple hernia group)
- patients without any history or presence of hernias (control group)
Exclusion Criteria:
- connective tissue disorder (Ehlers-Danloss/Marfan)
- presence of hernia upon clinical examination (control group)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Multiple hernia group
Males undergoing at least three repairs of abdominal wall hernias at three different anatomic locations.
Collagen turnover is analysed.
|
Type IV and V collagen synthesis and breakdown
|
Control group
Males without any history or presence of hernias
|
Type IV and V collagen synthesis and breakdown
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Type IV and V collagen synthesis and breakdown
Time Frame: 3 months
|
Products from type IV and V collagen synthesis and breakdown are measured in serum.
with ELISA from Nordic Bioscience A/S, Herlev, Denmark.
Specifically, the biomarker for type IV collagen synthesis (P4NP) and breakdown (C4M), and for type V collagen synthesis (P5CP) and breakdown (C5M) was measured.
The concentration unit for all parameters is ng/ml.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lars N Jorgensen, MD, Bispebjerg Hospital, Dept. of Surgery
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
August 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
April 1, 2016
First Submitted That Met QC Criteria
April 6, 2016
First Posted (Estimate)
April 12, 2016
Study Record Updates
Last Update Posted (Actual)
July 18, 2017
Last Update Submitted That Met QC Criteria
July 14, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H.A-2009-045
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hernia, Abdominal
-
Spital Limmattal SchlierenCompleted
-
Aesculap AGB.Braun Surgical SACompletedVentral Hernia | Abdominal Hernia | Abdominal Wall Defect | Fascial HerniaSpain
-
Meccellis BiotechRecruitingAbdominal Hernia | Abdominal Wall Defect | Abdominal Wall InjuryFrance
-
Musculoskeletal Transplant FoundationWashington University School of Medicine; Pines Surgical; Meridian Healthcare...CompletedHernia of Abdominal WallUnited States
-
Joanne TurnerNot yet recruitingAbdominal Surgery | Abdominal Hernia
-
AbbVieNot yet recruiting
-
Washington University School of MedicineCompletedHernia, VentralUnited States
-
University of Lausanne HospitalsCompletedPostoperative Complications | HerniaSwitzerland
-
Henares University HospitalCompletedHernia | Abdominal Wall Defect | Incisional Hernia | Abdominal Wall HerniaSpain
-
Assiut UniversityNot yet recruitingAbdominal Hernia
Clinical Trials on Collagen turnover
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownRectal Cancer | Wound Heal | Abdominoperineal ResectionNetherlands
-
Andrea RavidaSigmaGraft Inc.Enrolling by invitationSurgery | Peri-ImplantitisUnited States
-
Sel Sanayi Urunleri Ticaret ve Pazarlama A.S.Alpan Farma Ar-Ge Biyoteknolojileri Ltd.Sti.Not yet recruiting
-
The Cleveland ClinicCompletedPelvic Organ Prolapse
-
Sel Sanayi Urunleri Ticaret ve Pazarlama A.S.Alpan Farma Ar-Ge Biyoteknolojileri Ltd.Sti.RecruitingSkin Manifestations | Wrinkle | SkinTurkey
-
Ain Shams UniversityActive, not recruiting
-
Wuerzburg University HospitalCompleted
-
Ain Shams UniversityCompleted